OS
OSR Holdings, Inc.
OSRH · NASDAQ
$0.12 -47.05% (-$0.10)
1M -53.40%
Market Cap $3.86M
P/E Ratio -
Div. Yield -
ROE 15.59%
Bulios Fair Price
$0.08
31.3% downside
Current Price
$0.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OSRH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
87 /100
Cheap P/B 0.03x
P/S 2.13x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 895.19%
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Net margin 836.91%
Op. margin 933.75%
FCF margin 407.88%
Quality
0 /100
Poor ROE 15.59%
ROA 9.08%
Asset turnover 0.01x
Debt
46 /100
Moderate Current ratio 0.18x
Int. coverage -34.49x
Debt/Equity 0.00x
Stability
35 /100
Moderate EPS volatility 1,556.13%
Profitable years 0
Beta 0.58x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OSRH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kuk Hyoun Hwang
Employees
22
Headquarters
Bellevue
Upcoming events
02 DEC
Earnings
Upcoming earnings report